Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3692]

Study uncovers novel aspect of tumour evolution and potential targets for therapy

Study uncovers novel aspect of tumour evolution and potential targets for therapy

Clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

Clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

Cellular messengers improve cancer therapy

Cellular messengers improve cancer therapy

World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorised

World's first clinical trial with CAR-T technology for patients with T-cell leukaemia subtype authorised

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non...

Bioengineered synthetic gene circuits enhance cancer immunotherapies

Bioengineered synthetic gene circuits enhance cancer immunotherapies

ASH 2022: Venetoclax with CLIA highly effective in younger patients with newly diagnosed AML and high-risk MDS

ASH 2022: Venetoclax with CLIA highly effective in younger patients with newly diagnosed AML and high-risk MDS

ASH 2022: Researchers present new approach to understanding challenging CAR T-cell toxicities

ASH 2022: Researchers present new approach to understanding challenging CAR T-cell toxicities

ASH 2022: CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial

ASH 2022: CAR-T-cell shows promise in patients with lymphoma of the brain and spinal cord in early trial

How AI found the words to kill cancer cells

How AI found the words to kill cancer cells

More from ecancer